Skip to main navigation Skip to search Skip to main content

Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed

  • Alberto Borghetti
  • , Arturo Ciccullo
  • , Francesca Lombardi
  • , Diana Giannarelli
  • , Rosa Anna Passerotto
  • , Francesco Lamanna
  • , Antonella Carcagnì
  • , Damiano Farinacci
  • , Alex Dusina
  • , Gianmaria Baldin
  • , Maurizio Zazzi
  • , Simona Di Giambenedetto
  • Ospedale S. Salvatore
  • University of Siena

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)N/A-N/A
JournalOpen Forum Infectious Diseases
Volume11
DOIs
Publication statusPublished - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • HIV
  • lamivudine/dolutegravir
  • target trial emulation
  • three-drug regimen
  • virologically suppressed

Cite this